RecruitingNCT07140757

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Sponsor

M.D. Anderson Cancer Center

Enrollment

50 participants

Start Date

Aug 18, 2025

Study Type

OBSERVATIONAL

Conditions

Radiofrequency Ablation Papillary Thyroid Cancer Low Risk

Summary

To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.

Eligibility

Min Age: 18 Years

Inclusion Criteria9

Eligibility Criteria
Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC
Participant is over 18 years and is either not a surgical candidate or has declined surgery.
Capable and willing to provide written informed consent
Participant has one of the following diagnoses:
Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
Biopsy-proven indeterminate nodules (AUS or follicular neoplasm)
Papillary thyroid carcinoma (PTC) without metastasis
Locally recurrent thyroid cancer (\< 2 cm).

Exclusion Criteria2

Participants meeting any of the following criteria will be excluded:
Participants considered unsuitable for RFA by the treating physician

Interventions

OTHERQuestionnaire

This questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.